aspirin and abt-737

aspirin has been researched along with abt-737 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, LY; Lin, NM; Mao, SY; Pan, JP; Shi, J; Wang, SC; Xu, YS; Yan, YY; Yang, YP; Zhang, B; Zhang, C; Zhang, D1
Chen, CJ; Chen, WY; Kuan, YH; Li, JR; Liao, SL; Lu, HC; Ou, YC; Wang, JD; Yang, CP1

Other Studies

2 other study(ies) available for aspirin and abt-737

ArticleYear
Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737.
    Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:2

    Topics: Apoptosis; Aspirin; Autophagy; Biphenyl Compounds; Cell Line, Tumor; Humans; Neoplasms; Nitrophenols; p38 Mitogen-Activated Protein Kinases; Piperazines; Sulfonamides

2015
Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells.
    Biochemical and biophysical research communications, 2018, 07-12, Volume: 502, Issue:2

    Topics: Anticarcinogenic Agents; Apoptosis; Aspirin; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Humans; Kidney Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sulfonamides

2018